Education Speaker / Author - Marina Berenguer

De-novo fatty liver post LT: Is this a new disease?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Hepatology
- Surgery
- Marina Berenguer
- 2019 ILTS Toronto
The future of transplant oncology: Bridging the gap

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Marina Berenguer
- 2019 Consensus Conference
End-stage liver disease and liver transplantation

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Hepatology
- Marina Berenguer
- 2018 ILTS Consensus Conference
Mastering Viral Infections in Liver Transplantation: Management of HCV patients before transplantation

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Hepatology
- Surgery
- Marina Berenguer
- 2017 Joint International Congress
Working Groups for Immunosuppression Guidance: Immunosuppression Minimization Strategies

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Immunosuppression
- Avi Shaked
- 2017 Immunosuppression in Liver Transplantation - Park City
Update in LT for HCC: Impact of Immunosuppression on Hcc Recurrence after LT: With What? Or Avoid What?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Marina Berenguer
- 2016 ILTS Seoul
Retransplantation – It~s All About Selection: Are the New Anti-Virals a Game Changer in Selecting Candidates?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Other / multiple topics
- Marina Berenguer
- 2015 ILTS Chicago
DIRECTED ANTIVIRAL THERAPY FOR HEPATITIS C: A Lead into Transplantation

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Chronic Hepatitis C
- Marina Berenguer
- 2014 ILTS/ELITA/LICAGE London
PRACTICE GUIDELINES: Draft ILTS Guideline: Liver Transplantation for Alcoholic Liver Disease

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- General / Multiple topics
- Marina Berenguer
- 2014 ILTS/ELITA/LICAGE London
Focus on the Long-Term Outcomes in Liver Transplant Patients

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Marina Berenguer
- 2014 London Sponsored Symposia
HCV IN THE LIVER TRANSPLANT SETTING: WHERE ARE WE UP TO?: What are the Key Influences on Outcome in the Pre-DAA Era?

For ILTS members only, please join now or renew your membership.

For ILTS members only, please join now or renew your membership.
- Chronic Hepatitis C
- Marina Berenguer
- 2013 ILTS Sydney

International Liver Transplantation Society

The knowledge network for liver transplantation

Education Speaker / Author - Marina Berenguer

De-novo fatty liver post LT: Is this a new disease?

The future of transplant oncology: Bridging the gap

End-stage liver disease and liver transplantation

Mastering Viral Infections in Liver Transplantation: Management of HCV patients before transplantation

Working Groups for Immunosuppression Guidance: Immunosuppression Minimization Strategies

Update in LT for HCC: Impact of Immunosuppression on Hcc Recurrence after LT: With What? Or Avoid What?

Retransplantation – It~s All About Selection: Are the New Anti-Virals a Game Changer in Selecting Candidates?

DIRECTED ANTIVIRAL THERAPY FOR HEPATITIS C: A Lead into Transplantation

PRACTICE GUIDELINES: Draft ILTS Guideline: Liver Transplantation for Alcoholic Liver Disease

Focus on the Long-Term Outcomes in Liver Transplant Patients

HCV IN THE LIVER TRANSPLANT SETTING: WHERE ARE WE UP TO?: What are the Key Influences on Outcome in the Pre-DAA Era?

Specialty Sections

Content Directories